ArticleNMC case report journal2024
Chronic Subdural Hematoma in the Posterior Fossa Associated with Hearing Impairment during Warfarin Therapy, Improved by Middle Meningeal Artery Embolization: A Case Report.
Article in NMC case report journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic subdural hematoma (CSDH) in posterior fossa is rare, and its pathogenesis and treatment remain unclear. In this study, we report a case of a patient with CSDH in the posterior fossa who was taking warfarin and underwent middle meningeal artery (MMA) embolization successfully. A 59-year-old man taking warfarin for a mechanical aortic valve presented with a complaint of hearing impairment. He then developed headaches and was referred to our hospital after the previous physician identified CSDH above and below the left tentorium cerebelli on computed tomography (CT). We conducted MMA embolization with n-butyl-2-cyanoacrylate while continuing anticoagulation therapy. Right after the day of the surgery, symptoms of hearing impairment and right hemiplegia immediately improved. He was discharged after 10 days of hospitalization and was able to walk independently. His symptoms disappeared 20 days after surgery. There was no recurrence 100 days after surgery. In this study, we experienced a case of a CSDH in the posterior fossa that was clinically improved by MMA embolization. MMA embolization is a useful option for nonspecific CSDH without interruption of warfarin therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.